# PHARMFLOW_CURRENT_CHECKPOINT

**Date:** 2026-10-01  
**Track:** Production — Settings complete  
**Production branch:** `main`  
**Settings release PR:** #22 — squash merged  
**Settings production release commit:** `35a2588a158a8fc52613cb01f64d19e1f0842278`  
**Production startup syntax fix:** `73acdfecde3232f5fbb30ae7b54aeafe32e61f7f`  
**Production asset refresh commit:** `65743f05b34ab467aa99b0a4d33238508c0c4d6b`

## STATUS
Settings is **DONE**. The Product Owner verified the final Production smoke test after the startup regression was corrected.

## USER VERIFIED / DONE
- Barcode Control duplicate/cross-item recovery and recognized Receiving behavior.
- TEST003 Current Workspace reset with pharmacy barcode preservation.
- Historical delete confirmation using `DELETE`.
- Pharmacy-context receipt isolation.
- Pharmacies & Access KPI/search/edit/admin-email prefill behavior exercised during Settings acceptance.
- System Owner Reset Admin flow.
- Forced temporary-password gate and mandatory replacement before application access.
- New password completion, old temporary-password rejection, sign-out/sign-in cleanup.
- Normal Change Password validation, wrong-current-password handling, success and re-login.
- Settings account header.
- Session Paused PharmFlow identity presentation.
- Preparing PharmFlow loading presentation remains the accepted/frozen design.
- Production hard-refresh/startup smoke: **PASS**; Receiving opened normally after the syntax correction.

## DEFERRED / NON-BLOCKING
- Live Reset Admin attempt using a non-System-Owner account remains deferred by Product Owner. Security/authority code path was reviewed, but this exact runtime acceptance case is not USER VERIFIED.
- Other optional Settings acceptance passes explicitly deferred by Product Owner.

## SETTINGS RELEASE / CLEANUP
- Settings was promoted through the frozen release branch and PR #22 using **Squash Merge**.
- Temporary Session Paused preview hook removed.
- Obsolete Session Paused capsule paths removed.
- Hidden legacy Settings Workspace card and dead handlers removed.
- Production client uses canonical `pharmflow-password-admin`; no runtime client reference to the RC endpoint remains.
- Canonical password-admin is ACTIVE v2 with JWT verification enabled.
- RC Edge Function remains temporarily deployed as an inactive-by-client rollback artifact; do not use it for normal runtime. Removal can be performed later when a supported deletion path is available.
- No destructive production-data migration was performed.

## PRODUCTION REGRESSION + ROOT-CAUSE FIX
Immediately after release, Production remained on **Preparing PharmFlow**. Browser Console exposed:
`Uncaught SyntaxError: Unexpected token '}' — app.js:1390`.

Root cause: removal of the legacy Settings workspace handlers left an extra closing-brace block in `js/app.js`, preventing the application bootstrap script from parsing.

Correction:
1. Removed only the malformed extra closing block in `js/app.js`.
2. Refreshed the `js/app.js` asset version in `index.html` so GitHub Pages clients receive the corrected bundle.
3. Product Owner performed the Production refresh and reported **PASS**.

Classification: **deployment/release code regression — JavaScript parse/startup**, not Supabase, Receiving data, Active Order Manifest, or workspace synchronization.

## DATABASE / SUPABASE
Shared Supabase project: `zznoshzcyxmtwfbznjyr`.
Applied migration history includes PHASE2C1168 through PHASE2C1171. Current database definition of `owner_update_pharmacy_identity_v1` already contains the PHASE2C1172 HHP084 protected-code guard although PHASE2C1172 is not listed in migration history.
Do not blindly reapply PHASE2C1172 merely to reconcile migration bookkeeping.

## CRITICAL NON-REGRESSION
Preserve Receiving ledger/transaction semantics, Active Order Manifest, durable queue, authentication/tenant isolation, Global GTIN boundaries, multi-PC synchronization, reports/exports, Expiry behavior, and the accepted Preparing PharmFlow loading presentation.

## EXACT NEXT ACTION
Settings is closed. Begin the next approved PharmFlow development phase from current Production `main`. Before new implementation, classify the requested change and protect the non-regression boundaries above.
